Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	283.92	49719.65	12950.41
Graham Fair Price	41.42	51.91	36.71
PEG	-70.66	0.10	-0.34
Price/Book	12.96	2.42	2.14
Price/Cash Flow	100.00	117.37	0.00
Prices/Earnings	-43.52	10.16	18.00
Price/Sales	-60.12	11.38	28.53
Price/FCF	100.00	117.37	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-1.48	0.99	1.00
Operating Margin	-64.70	0.16	0.46
ROA	100.00	< 0.005	< 0.005
ROE	0.03	0.06	100.00
ROIC	< 0.005	< 0.005	-43.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	1.16	-0.06	1815.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.04	0.00	inf
EPS QOQ	-0.52	1.01	92.53
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	-0.63	1.83	191.71
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	92826.45	100.00
Days Sales Outstanding (DSO)	0.00	13.40	100.00
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.66	0.81	22.06
Quick Ratio	58.61	-0.33	-99.44
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	44.88	44.88	< 0.005
Cash	146.72	-146.72	< 0.005
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.92	100.00
Revenue	3.37	9.54	183.28
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	58.61	0.34	-99.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-20048.00	12444.00	-37.93
Naive Interpretation	Member

06 - Financial Health · Bad

Rating